Atritech Raises $22 Million

Atritech Inc., a Minneapolis-based developer of minimally-invasive technologies for the prevention of atrial fibrillation related stroke, has raised $22 million in Series D funding. SightlLine Partners led the deal, and was joined by fellow return backers like Prism VentureWorks, Split Rock Partners, Tullis-Dickerson, Thoma Cressey Bravo and Affinity Capital Management. The company has raised over $62 million in total VC funding since 2000. www.atritech.net